Cardiac Imaging in Heart Failure with Comorbidities
Imaging modalities stand at the frontiers for progress in congestive heart failure (CHF) screening, risk stratification and monitoring. Advancements in echocardiography (ECHO) and Magnetic Resonance Imaging (MRI) have allowed for improved tissue characterizations, cardiac motion analysis, and cardiac performance analysis under stress. Common cardiac comorbidities such as hypertension, metabolic syndromes and chronic renal failure contribute to cardiac remodeling, sharing similar pathophysiological mechanisms starting with interstitial changes, structural changes and finally clinical CHF. These imaging techniques can potentially detect changes earlier. Such information could have clinical benefits for screening, planning preventive therapies and risk stratifying patients. Imaging reports have often focused on traditional measures without factoring these novel parameters. This review is aimed at providing a synopsis on how we can use this information to assess and monitor improvements for CHF with comorbidities..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Current cardiology reviews - 13(2017), 1, Seite 63-75 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chiew Wong [VerfasserIn] |
---|
Links: |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
OLC1991584210 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | OLC1991584210 | ||
003 | DE-627 | ||
005 | 20230508131534.0 | ||
007 | tu | ||
008 | 170303s2017 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a PQ20170301 |
035 | |a (DE-627)OLC1991584210 | ||
035 | |a (DE-599)GBVOLC1991584210 | ||
035 | |a (PRQ)b1537-f41c383e659f893cfdb087dd2a029c956d0ad78ab1ad19f0c08b0da82e542f8f0 | ||
035 | |a (KEY)0574726020170000013000100063cardiacimaginginheartfailurewithcomorbidities | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q ZDB |
100 | 0 | |a Chiew Wong |e verfasserin |4 aut | |
245 | 1 | 0 | |a Cardiac Imaging in Heart Failure with Comorbidities |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
520 | |a Imaging modalities stand at the frontiers for progress in congestive heart failure (CHF) screening, risk stratification and monitoring. Advancements in echocardiography (ECHO) and Magnetic Resonance Imaging (MRI) have allowed for improved tissue characterizations, cardiac motion analysis, and cardiac performance analysis under stress. Common cardiac comorbidities such as hypertension, metabolic syndromes and chronic renal failure contribute to cardiac remodeling, sharing similar pathophysiological mechanisms starting with interstitial changes, structural changes and finally clinical CHF. These imaging techniques can potentially detect changes earlier. Such information could have clinical benefits for screening, planning preventive therapies and risk stratifying patients. Imaging reports have often focused on traditional measures without factoring these novel parameters. This review is aimed at providing a synopsis on how we can use this information to assess and monitor improvements for CHF with comorbidities. | ||
700 | 0 | |a Sylvia Chen |4 oth | |
700 | 0 | |a Pupalan Iyngkaran |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Current cardiology reviews |d Sharjah [u.a.] : Bentham Science Publishers, 2005 |g 13(2017), 1, Seite 63-75 |w (DE-627)528856944 |w (DE-600)2296217-7 |x 1573-403X |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2017 |g number:1 |g pages:63-75 |
856 | 4 | 2 | |u http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1573-403X&volume=13&issue=1&spage=63 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
951 | |a AR | ||
952 | |d 13 |j 2017 |e 1 |h 63-75 |